Business Wire11d
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A. (EPA: BIM) for patent ...
Nasdaq10d
QIAGEN Files Patent Complaint Against BioMérieux To Protect QuantiFERON Technology
(RTTNews) - QIAGEN N.V. (QGEN) announced that it has filed a complaint against bioMrieux S.A. for patent infringement, reinforcing its commitment to protecting the scientific advancements behind ...
ETF Daily News11d
What is Zacks Research’s Estimate for Qiagen Q1 Earnings?
Qiagen (NYSE:QGEN – Free Report) – Investment analysts at Zacks Research cut their Q1 2025 earnings per share estimates for Qiagen in a research note issued on Wednesday, February 26th.